HealthCor Management’s DexCom DXCM Stock Holding History

HealthCor Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$36.4M	Buy	321,380 +67,880	+27%	+$7.45M	33.35%	2
2022 Q3	$20.4M	Buy	253,500 +178,720	+239%	+$15.1M	2.55%	16
2022 Q2	$5.57M	Buy	+74,780	New	+$6.82M	0.56%	37
2021 Q3	–	Sell	-203,560	Closed	-$21.7M	–	77
2021 Q2	$21.7M	Sell	203,560 -364,880	-64%	-$35M	0.87%	37
2021 Q1	$51.1M	Buy	+568,440	New	+$53.4M	1.81%	21
2019 Q2	–	Sell	-2,920,400	Closed	-$87M	–	55
2019 Q1	$87M	Sell	2,920,400 -2,954,608	-50%	-$104M	3.51%	10
2018 Q4	$176M	Buy	5,875,008 +3,976,288	+209%	+$126M	5.5%	3
2018 Q3	$67.9M	Sell	1,898,720 -559,800	-23%	-$17.4M	2.25%	20
2018 Q2	$58.4M	Buy	+2,458,520	New	+$52.1M	1.85%	22
2017 Q2	–	Sell	-900,000	Closed	-$19.1M	–	44
2017 Q1	$19.1M	Sell	900,000 -614,600	-41%	-$12M	0.87%	28
2016 Q4	$22.6M	Buy	+1,514,600	New	+$26.8M	1.28%	24
2016 Q3	–	Sell	-1,584,120	Closed	-$31.4M	–	42
2016 Q2	$31.4M	Sell	1,584,120 -5,515,880	-78%	-$93.9M	1.71%	21
2016 Q1	$121M	Buy	7,100,000 +4,100,000	+137%	+$68.5M	6.83%	3
2015 Q4	$61.4M	Buy	3,000,000 +2,900,000	+2,900%	+$60.3M	3.73%	11
2015 Q3	$2.15M	Sell	100,000 -970,000	-91%	-$21.6M	0.12%	42
2015 Q2	$21.4M	Buy	+1,070,000	New	+$18.8M	1.08%	30

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HealthCor Management's DXCM Position: Q4 2022 in Review

HealthCor Management increased its DexCom (DXCM) stake by 27% in Q4 2022, buying an estimated $7.45M and bringing the position to 321,380 shares worth $36.4M. The position accounts for 33.35% of the portfolio, ranked #2.

HealthCor Management first reported a position in DXCM in Q2 2015 and has held it in 16 quarters since. The position peaked at $176M in Q4 2018. 919 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

HealthCor Management held 321,380 shares of DexCom worth $36.4M as of Q4 2022.
HealthCor Management bought 67,880 DexCom shares in Q4 2022, an estimated $7.45M.
DexCom made up 33.35% of HealthCor Management's portfolio in Q4 2022, its #2 holding.
HealthCor Management first reported a position in DexCom in Q2 2015 and has held it in 16 quarters since.
HealthCor Management's DexCom position peaked at $176M in Q4 2018.
919 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.